In vitro evidence for immune activating effect of specific AGE structures retained in uremia
Open Access
- 1 November 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (5) , 1873-1880
- https://doi.org/10.1111/j.1523-1755.2004.00961.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003
- Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsinKidney International, 2001
- Reactive carbonyl compounds related uremic toxicity (“carbonyl stress”)Kidney International, 2001
- Reactive Carbonyl Compounds as Uremic ToxinsPublished by S. Karger AG ,2001
- Increased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin VitroBiochemical and Biophysical Research Communications, 1998
- Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 1996
- Advanced glycation end-products in diabetic nephropathyNephrology Dialysis Transplantation, 1996
- Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albuminsProtein Journal, 1995
- Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxalZeitschrift für Lebensmittel-Untersuchung und Forschung, 1994
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988